ONCOLYTICS BIOTECH INC.: retained_earnings
| Value | {"amount": -400736000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | ONCOLYTICS BIOTECH INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:20:03.381402+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/beac28a4-9b36-463d-b02e-ce438a0b31fa
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001129928-26-000020 · Open the official SEC filing →Retrieved: 2026-08-19T11:20:03.381402+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001129928/retained-earnings/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/beac28a4-9b36-463d-b02e-ce438a0b31fa
History
- no predecessors — first report